Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review-Reference-Cited by-同舟云学术

Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review

Published:2022-10-12 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Fatima Hameeda,Nwankwo Ijeoma,Anam Mahvish,Maharjan Shrinkhala,Amjad Zainab,Abaza Abdelrahman,Vasavada Advait M,Sadhu Akhil,Valencia Carla,Khan Safeera

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference31 articles.

1. Chapter 1: Definition and classification of CKD;Kidney Int Suppl (2011),2013

2. CKD Evaluation and Management. (2013). Accessed. 6/25/2022: https://kdigo.org/guidelines/ckd-evaluation-and-management/.

3. Global prevalence of chronic kidney disease - a systematic review and meta-analysis;Hill NR;PLoS One,2016

4. Atrial fibrillation and chronic kidney disease;Benn M;Eur Heart J,2021

5. Risk and complications of venous thromboembolism in dialysis patients;Molnar AO;Nephrol Dial Transplant,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Apixaban for the prevention of thrombosis in arteriovenous grafts;European Journal of Translational Myology;2024-01-15

2. Efficacy and safety of Apixaban for the prevention of thrombosis in arteriovenous grafts;EUR J TRANSL MYOL;2024

3. Safety of rivaroxaban in elderly patients;Glavvrač (Chief Medical Officer);2023-12-22

4. Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against;Medical alphabet;2023-11-08

5. Blood Clotting Complications in Dialysis;Complications in Dialysis;2023